ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07885
0,00%
Bitcoin
60.707,38
-0,14%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cytek Biosciences Inc (CTKB)

  7. Cytek Biosciences Inc (CTKB) News

CTKB

Cytek Biosciences (CTKB)

Cytek Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CTKB
DatumZeitQuelleÜberschriftSymbolFirma
08/05/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTKBCytek Biosciences Inc
08/05/202422h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
08/05/202422h05GlobeNewswire Inc.Cytek Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ:CTKBCytek Biosciences Inc
30/04/202423h30GlobeNewswire Inc.Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and EuropeNASDAQ:CTKBCytek Biosciences Inc
29/04/202415h00GlobeNewswire Inc.Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:CTKBCytek Biosciences Inc
19/03/202413h00GlobeNewswire Inc.Cytek® Biosciences Names William McCombe Chief Financial OfficerNASDAQ:CTKBCytek Biosciences Inc
09/03/202400h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
09/03/202400h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
09/03/202400h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
09/03/202400h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
09/03/202400h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
07/03/202423h30GlobeNewswire Inc.Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis SolutionsNASDAQ:CTKBCytek Biosciences Inc
01/03/202412h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
28/02/202423h05GlobeNewswire Inc.Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 OutlookNASDAQ:CTKBCytek Biosciences Inc
27/02/202412h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
22/02/202423h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
22/02/202423h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
22/02/202423h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
22/02/202423h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
22/02/202423h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
22/02/202423h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
14/02/202422h07Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CTKBCytek Biosciences Inc
07/02/202422h10GlobeNewswire Inc.Cytek Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CTKBCytek Biosciences Inc
07/02/202422h05GlobeNewswire Inc.Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:CTKBCytek Biosciences Inc
17/01/202423h30GlobeNewswire Inc.Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific DiscoveriesNASDAQ:CTKBCytek Biosciences Inc
09/01/202412h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
08/01/202415h00GlobeNewswire Inc.Cytek Biosciences Announces Preliminary Full Year 2023 Revenue ResultsNASDAQ:CTKBCytek Biosciences Inc
28/12/202322h05GlobeNewswire Inc.Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
27/12/202323h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
21/12/202323h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CTKB

Kürzlich von Ihnen besucht

AMEX
XLV
Health Care Select Sector
DBI
SDXP
SDAX
FX
EURUSD
Euro vs US Dollar
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
TUI1
Tui
TG
DTE
Deutsche Telekom
NASDAQ
MSFT
Microsoft
AMEX
XLE
Energy Select Sector SPDR
NYSE
MRK
Merck
TG
DBK
Deutsche Bank
USOTC
BNPQY
BNP Paribas (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
DBI
MDAX
MDAX
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten